Show simple item record

Prevence nosokomiálních infekcí
dc.contributor.advisorDuška, František
dc.creatorMourud, Heidi Riddervold
dc.date.accessioned2018-09-13T10:37:23Z
dc.date.available2018-09-13T10:37:23Z
dc.date.issued2010
dc.identifier.urihttp://hdl.handle.net/20.500.11956/30027
dc.description.abstractNosocomial infection and the importance of its prevention where first recognised by Dr. Ingaz Semmelweis in the 1850s, who discovered the effect of hand washing and disinfectant. Nowadays, nosocomial infections are a common cause of mortality and morbidity affecting 5-10 % of all hospitalised patients. It is further a major economical burden, estimated to cost $ 4,5 billion per year in the USA. The most common diseases occurring in hospitalised patients are urinary tract infections, pnemonia (VAP and HAP), catheter related bloodstream infections, surgical site infections and gastroenteritis. The most frequent and most important causative agents of these infections are Gram positive (Staphylococci, Enterococci) and Gram negatives (Enterobactericae, Pseudomonas, Actinobacter) bacterie. There are different types of patient affected, but in general do they have one or more risk factors. These risk factors include immunocompromised host, prolonged hospital stay, severe underlying ilness, need for frequent medical intervention, prolonged treatment with antibiotica or the presence of invasive device, catheter or endotracheal tube. Previous antibiotic treatment is also a risk because it impairs normal symbiotic bacterial flora and allowing colonisation with multiresistant strains (MDR). Thus, ICU patient are...en_US
dc.languageEnglishcs_CZ
dc.language.isoen_US
dc.publisherUniverzita Karlova, 3. lékařská fakultacs_CZ
dc.titlePrevention of Nosocomial Infectionsen_US
dc.typediplomová prácecs_CZ
dcterms.created2010
dcterms.dateAccepted2010-04-07
dc.description.departmentÚstav biochemie, buněčné a molekulární biologiecs_CZ
dc.description.departmentDepartment of Biochemistry, Cell and Molecular Biologyen_US
dc.description.facultyThird Faculty of Medicineen_US
dc.description.faculty3. lékařská fakultacs_CZ
dc.identifier.repId76768
dc.title.translatedPrevence nosokomiálních infekcícs_CZ
dc.identifier.aleph001223994
thesis.degree.nameMUDr.
thesis.degree.levelmagisterskécs_CZ
thesis.degree.discipline-cs_CZ
thesis.degree.discipline-en_US
thesis.degree.programGeneral Medicineen_US
thesis.degree.programVšeobecné lékařstvícs_CZ
uk.faculty-name.cs3. lékařská fakultacs_CZ
uk.faculty-name.enThird Faculty of Medicineen_US
uk.faculty-abbr.cs3.LFcs_CZ
uk.degree-discipline.cs-cs_CZ
uk.degree-discipline.en-en_US
uk.degree-program.csVšeobecné lékařstvícs_CZ
uk.degree-program.enGeneral Medicineen_US
thesis.grade.csVýborněcs_CZ
thesis.grade.enExcellenten_US
uk.abstract.enNosocomial infection and the importance of its prevention where first recognised by Dr. Ingaz Semmelweis in the 1850s, who discovered the effect of hand washing and disinfectant. Nowadays, nosocomial infections are a common cause of mortality and morbidity affecting 5-10 % of all hospitalised patients. It is further a major economical burden, estimated to cost $ 4,5 billion per year in the USA. The most common diseases occurring in hospitalised patients are urinary tract infections, pnemonia (VAP and HAP), catheter related bloodstream infections, surgical site infections and gastroenteritis. The most frequent and most important causative agents of these infections are Gram positive (Staphylococci, Enterococci) and Gram negatives (Enterobactericae, Pseudomonas, Actinobacter) bacterie. There are different types of patient affected, but in general do they have one or more risk factors. These risk factors include immunocompromised host, prolonged hospital stay, severe underlying ilness, need for frequent medical intervention, prolonged treatment with antibiotica or the presence of invasive device, catheter or endotracheal tube. Previous antibiotic treatment is also a risk because it impairs normal symbiotic bacterial flora and allowing colonisation with multiresistant strains (MDR). Thus, ICU patient are...en_US
uk.file-availabilityV
uk.publication.placePrahacs_CZ
uk.grantorUniverzita Karlova, 3. lékařská fakulta, Ústav biochemie, buněčné a molekulární biologiecs_CZ
thesis.grade.code1


Files in this item

Thumbnail
Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


© 2017 Univerzita Karlova, Ústřední knihovna, Ovocný trh 560/5, 116 36 Praha 1; email: admin-repozitar [at] cuni.cz

Za dodržení všech ustanovení autorského zákona jsou zodpovědné jednotlivé složky Univerzity Karlovy. / Each constituent part of Charles University is responsible for adherence to all provisions of the copyright law.

Upozornění / Notice: Získané informace nemohou být použity k výdělečným účelům nebo vydávány za studijní, vědeckou nebo jinou tvůrčí činnost jiné osoby než autora. / Any retrieved information shall not be used for any commercial purposes or claimed as results of studying, scientific or any other creative activities of any person other than the author.

DSpace software copyright © 2002-2015  DuraSpace
Theme by 
@mire NV